Prison health in Belarus
Belarusian political prisoners report worsening medical care, particularly since a crackdown on political dissent. Ed Holt reports.
Source: www.thelancet.com
Categories: General Journals & Societ, General Medicine News
Tweets with this article
The Lancet
Belarusian political prisoners report worsening medical care, particularly since a crackdown on political dissent.
Ed Holt reports: https://t.co/WYSPev0GXe
Ed Holt reports: https://t.co/WYSPev0GXeRelated Articles
Combination Therapies and Resistance-Based Approaches Reshape EGFR Care
Mya Tran, PharmD, BCOP, offers insights for navigating the complex treatment landscape for non-small cell lung cancer.
Targeted alerts may help doctors choose the right antibiotics
Large NIH-funded studies show real-time alerts help doctors reduce unnecessary use of strong antibiotics
FDA Approves Larotrectinib for Adult and Pediatric Patients With NTRK Gene Fusion-Positive Solid Tumors
The approval is for those with metastatic disease or in whom surgical resection is likely to result in severe morbidity, have no satisfactory alternative treatments,…
ACP Advocate | ACP Online
The ACP Advocate is a bi-weekly e-newsletter that provides ACP members with news about public policy issues affecting internal medicine.
Study: Vitamin B12 Levels Within “Normal” Range Linked to Cognitive Decline in Older Adults
Current recommended levels of vitamin B12 might not be sufficient to protect against neurological decline.
ACP Advocate | ACP Online
The ACP Advocate is a bi-weekly e-newsletter that provides ACP members with news about public policy issues affecting internal medicine.
How Lifestyle Changes and Self-Care Can Improve Your Eczema
Find out how small changes to the way you live your life can reduce the frequency and severity of your eczema flares.
New senate bill would create Medicare payment pathway for AI-enabled devices
Experts say the lack of a consistent payment mechanism through Medicare has become a major roadblock to adoption.
AZD0780, Novel Oral PCSK9 Inhibitor, Demonstrates Major LDL Cholesterol Reductions
When used in combination with background statin therapy, AZD0780 resulted in major reductions in low-density lipoprotein cholesterol (LDL-C) and achievements of guideline-recommended LDL-C goals.
From coronary artery disease to atherosclerotic coronary artery disease: what is in a name?
Atherosclerosis starts early in life, progresses with age, with lesions distributed across the vasculature, including coronaries, and is responsible for adverse cardiac events, such as…
